Clinical Trials Directory

Trials / Completed

CompletedNCT05448690

Comparative Effectiveness of Different Surgical Approaches for Giant Pituitary Adenomas

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
600 (actual)
Sponsor
Huashan Hospital · Academic / Other
Sex
All
Age
6 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The surgical treatment strategy for giant invasive pituitary adenoma is one of the current hot spots in the field of clinical research on pituitary adenoma. A comprehensive literature search resulted in numerous previous studies to investigate the efficacy, advantages and disadvantages of different surgical options. A single approach (transnasal or craniotomy) is theoretically less invasive and has a shorter hospital stay for the patient, but may result in postoperative bleeding due to residual tumor and damage to the intracranial vessels adhering to the tumor. The advantage of the combined approach is that the tumor can be removed to the greatest extent possible. In addition, postoperative suprasellar hemorrhage can be prevented by careful hemostasis or intracranial drainage by the transcranial team if necessary. In this way, the risk of postoperative bleeding due to residual tumor can be significantly reduced. In some cases, waiting a few months after the initial surgery for a second-stage procedure may also be an option when the patient's condition does not allow for a combined access procedure, when the tumor is hard, or when the blood preparation is insufficient. However, staged surgery increases the financial burden on the patient, and local scar formation may make second-stage surgery more difficult and decrease the likelihood of endocrine remission of functional pituitary tumors. Given the complexity of the treatment of giant invasive pituitary adenoma, there is a need to conduct studies comparing the combined transnasal cranial approach, the single access transnasal or cranial approach, and the staged approach simultaneously to assess whether the combined transnasal cranial approach is superior to the single access transnasal or cranial approach or the staged approach in improving the tumor resection rate in giant invasive pituitary adenoma.

Conditions

Interventions

TypeNameDescription
PROCEDURETwo different approachesPlease refer to Groups
PROCEDURENon-combined approachEither transnasal, transcranial or a staged approach

Timeline

Start date
2022-01-01
Primary completion
2023-01-01
Completion
2023-01-01
First posted
2022-07-07
Last updated
2024-10-29

Locations

13 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05448690. Inclusion in this directory is not an endorsement.